Protective effects of tetramethylpyrazine on rat retinal cell cultures

Neurochemistry International

Volumn 52, Issue 6, 2008, Pages 1176-1187

  Yang, Zhikuan ^a   Zhang, Qingjiong ^a   Ge, Jian ^a   Tan, Zhiqun ^b  

^a SUN YAT SEN UNIVERSITY   (China)

^b UNIVERSITY OF CALIFORNIA   (United States)

Author keywords

Cell death; Neuroprotection; Oxidative stress; Retinal cell culture; Tetramethylpyrazine

Indexed keywords

HUMANIN; HYDROGEN PEROXIDE; MICROTUBULE ASSOCIATED PROTEIN 2; PEPTIDE; RATTIN; REACTIVE OXYGEN METABOLITE; TETRAMETHYLPYRAZINE; UNCLASSIFIED DRUG;

ANALYTIC METHOD; ANIMAL CELL; ARTICLE; CELL CULTURE; CELL DEGENERATION; CELL PROTECTION; CELL STRUCTURE; CELL SURVIVAL; CHEMICAL ANALYSIS; CONTROLLED STUDY; LETHAL DOSE; LIPID PEROXIDATION; MITOCHONDRIAL MEMBRANE POTENTIAL; NERVE CELL; NONHUMAN; PRIORITY JOURNAL; RAT; RETINA CELL;

ANIMALS; ANIMALS, NEWBORN; CELL DEATH; CELL SURVIVAL; CELLS, CULTURED; COCULTURE TECHNIQUES; HYDROGEN PEROXIDE; MICROTUBULE-ASSOCIATED PROTEINS; NERVE DEGENERATION; NEUROGLIA; NEURONS; NEUROPROTECTIVE AGENTS; OXIDATIVE STRESS; PROTEINS; PYRAZINES; RATS; RATS, SPRAGUE-DAWLEY; REACTIVE OXYGEN SPECIES; RETINA; RETINAL DEGENERATION; RNA, SMALL INTERFERING; SIGNAL TRANSDUCTION;

RATTUS;

EID: 40949084677     PISSN: 01970186     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.neuint.2007.12.008     Document Type: Article

References (43)

1. Bahr M. Live or let die-retinal ganglion cell death and survival during development and in the lesioned adult CNS. Trends Neurosci. 23 (2000) 483-490
2. Barnham K.J., Masters C.L., and Bush A.I. Neurodegenerative diseases and oxidative stress. Nat. Rev. Drug Discov. 3 (2004) 205-214
3. Beatty S., Koh H., Phil M., Henson D., and Boulton M. The role of oxidative stress in the pathogenesis of age-related macular degeneration. Surv. Ophthalmol. 45 (2000) 115-134
4. Brewer G.J., Torricelli J.R., Evege E.K., and Price P.J. Optimized survival of hippocampal neurons in B27-supplemented neurobasal, a new serum-free medium combination. J. Neurosci. Res. 35 (1993) 567-576
5. Cai J., Nelson K.C., Wu M., Sternberg Jr. P., and Jones D.P. Oxidative damage and protection of the RPE. Prog. Retin. Eye Res. 19 (2000) 205-221
6. Caricasole A., Bruno V., Cappuccio I., Melchiorri D., Copani A., and Nicoletti F. A novel rat gene encoding a Humanin-like peptide endowed with broad neuroprotective activity. FASEB J. 16 (2002) 1331-1333
7. Casetta I., Govoni V., and Granieri E. Oxidative stress, antioxidants and neurodegenerative diseases. Curr. Pharm. Des. 11 (2005) 2033-2052
8. Cheng X.R., Zhang L., Hu J.J., Sun L., and Du G.H. Neuroprotective effects of tetramethylpyrazine on hydrogen peroxide-induced apoptosis in PC12 cells. Cell Biol. Int. (2006)
9. Dehmelt L., and Halpain S. Actin and microtubules in neurite initiation: are MAPs the missing link?. J. Neurobiol. 58 (2004) 18-33
10. Dehmelt L., and Halpain S. The MAP2/Tau family of microtubule-associated proteins. Genome Biol. 6 (2005) 204
11. Fan L.H., Wang K.Z., Cheng B., Wang C.S., and Dang X.Q. Anti-apoptotic and neuroprotective effects of tetramethylpyrazine following spinal cord ischemia in rabbits. BMC Neurosci. 7 (2006) 48
12. Farkas R.H., and Grosskreutz C.L. Apoptosis, neuroprotection, and retinal ganglion cell death: an overview. Int. Ophthalmol. Clin. 41 (2001) 111-130
13. Ferreira I.L., Duarte C.B., Neves A.R., and Carvalho A.P. Culture medium components modulate retina cell damage induced by glutamate, kainate or "chemical ischemia". Neurochem. Int. 32 (1998) 387-396
14. Fifre A., Sponne I., Koziel V., Kriem B., Yen Potin F.T., Bihain B.E., Olivier J.L., Oster T., and Pillot T. Microtubule-associated protein MAP1A, MAP1B, and MAP2 proteolysis during soluble amyloid beta-peptide-induced neuronal apoptosis. Synergistic involvement of calpain and caspase-3. J. Biol. Chem. 281 (2006) 229-240
15. Fontaine-Lenoir V., Chambraud B., Fellous A., David S., Duchossoy Y., Baulieu E.E., and Robel P. Microtubule-associated protein 2 (MAP2) is a neurosteroid receptor. Proc. Natl. Acad Sci. U.S.A. 103 (2006) 4711-4716
16. Ge J.Y., and Zhang Z.L. Progress in pharmacology and clinical application of Ligusticum wallichii. Zhongguo Zhong Xi Yi Jie He Za Zhi 14 (1994) 638-640
17. Guo B., Zhai D., Cabezas E., Welsh K., Nouraini S., Satterthwait A.C., and Reed J.C. Humanin peptide suppresses apoptosis by interfering with Bax activation. Nature 423 (2003) 456-461
18. Guo L., Salt T.E., Maass A., Luong V., Moss S.E., Fitzke F.W., and Cordeiro M.F. Assessment of neuroprotective effects of glutamate modulation on glaucoma-related retinal ganglion cell apoptosis in vivo. Invest. Ophthalmol. Vis. Sci. 47 (2006) 626-633
19. Hashimoto Y., Niikura T., Tajima H., Yasukawa T., Sudo H., Ito Y., Kita Y., Kawasumi M., Kouyama K., Doyu M., Sobue G., Koide T., Tsuji S., Lang J., Kurokawa K., and Nishimoto I. A rescue factor abolishing neuronal cell death by a wide spectrum of familial Alzheimer's disease genes and Abeta. Proc. Natl. Acad Sci. U.S.A. 98 (2001) 6336-6341
20. Kao T.K., Ou Y.C., Kuo J.S., Chen W.Y., Liao S.L., Wu C.W., Chen C.J., Ling N.N., Zhang Y.H., and Peng W.H. Neuroprotection by tetramethylpyrazine against ischemic brain injury in rats. Neurochem. Int. 48 (2006) 166-176
21. Kapin M.A., Doshi R., Scatton B., DeSantis L.M., and Chandler M.L. Neuroprotective effects of eliprodil in retinal excitotoxicity and ischemia. Invest. Ophthalmol. Vis. Sci. 40 (1999) 1177-1182
22. Krichevsky A.M., and Kosik K.S. RNAi functions in cultured mammalian neurons. Proc. Natl. Acad Sci. U.S.A. 99 (2002) 11926-11929
23. Kroemer G., and Reed J.C. Mitochondrial control of cell death. Nat. Med. 6 (2000) 513-519
24. Levin L.A. Mechanisms of optic neuropathy. Curr. Opin. Ophthalmol. 8 (1997) 9-15
25. Li X., Yang L., Kang F., Zhang S., Li G., Han Y., and Zhai Y. The protective effect of ligustrazine on optic nerve axons in rabbit eyes with continuous elevated IOP. Zhonghua Yan Ke Za Zhi 36 (2000) 442-444, 429
26. Li Y., Schlamp C.L., and Nickells R.W. Experimental induction of retinal ganglion cell death in adult mice. Invest. Ophthalmol. Vis. Sci. 40 (1999) 1004-1008
27. Liao S.L., Kao T.K., Chen W.Y., Lin Y.S., Chen S.Y., Raung S.L., Wu C.W., Lu H.C., and Chen C.J. Tetramethylpyrazine reduces ischemic brain injury in rats. Neurosci. Lett. 372 (2004) 40-45
28. Lin M.T., and Beal M.F. Mitochondrial dysfunction and oxidative stress in neurodegenerative diseases. Nature 443 (2006) 787-795
29. Luo X., Heidinger V., Picaud S., Lambrou G., Dreyfus H., Sahel J., and Hicks D. Selective excitotoxic degeneration of adult pig retinal ganglion cells in vitro. Invest. Ophthalmol. Vis. Sci. 42 (2001) 1096-1106
30. Ni J.W., Matsumoto K., and Watanabe H. Tetramethylpyrazine improves spatial cognitive impairment induced by permanent occlusion of bilateral common carotid arteries or scopolamine in rats. Jpn. J. Pharmacol. 67 (1995) 137-141
31. Nishimoto I., Matsuoka M., and niikura T. Unravelling the role of humanin. Trends Mol. Med. 10 (2004) 102-105
32. Pang P.K., Shan J.J., and Chiu K.W. Tetramethylpyrazine, a calcium antagonist. Planta Med. 62 (1996) 431-435
33. Parone P., Priault M., James D., Nothwehr S.F., and Martinou J.C. Apoptosis: bombarding the mitochondria. Essays Biochem. 39 (2003) 41-51
34. Richer S. Antioxidants and the eye. Int. Ophthalmol. Clin. 40 (2000) 1-16
35. Shih Y.H., Wu S.L., Chiou W.F., Ku H.H., Ko T.L., and Fu Y.S. Protective effects of tetramethylpyrazine on kainate-induced excitotoxicity in hippocampal culture. Neuroreport 13 (2002) 515-519
36. Tan Z., Sun X., Hou F.S., Oh H.W., Hilgenberg L.G., Hol E.M., van Leeuwen F.W., Smith M.A., O'Dowd D.K., and Schreiber S.S. Mutant ubiquitin found in Alzheimer's disease causes neuritic beading of mitochondria in association with neuronal degeneration. Cell Death Differ. 14 (2007) 1721-1732
37. Tan Z., Tu W., and Schreiber S.S. Downregulation of free ubiquitin: a novel mechanism of p53 stabilization and neuronal cell death. Brain Res. Mol. Brain Res. 91 (2001) 179-188
38. Tezel G. Oxidative stress in glaucomatous neurodegeneration: mechanisms and consequences. Prog. Retin. Eye Res. 25 (2006) 490-513
39. Wang Y., Chang C.F., Morales M., Chou J., Chen H.L., Chiang Y.H., Lin S.Z., Cadet J.L., Deng X., Wang J.Y., Chen S.Y., Kaplan P.L., and Hoffer B.J. Bone morphogenetic protein-6 reduces ischemia-induced brain damage in rats. Stroke 32 (2001) 2170-2178
40. Xu H., Shi D.Z., and Guan C.Y. Clinical application and pharmacological actions of ligustrazine. Zhongguo Zhong Xi Yi Jie He Za Zhi 23 (2003) 376-379
41. Yang J.N., Chen J.M., Luo L., Lin S.C., Li D., and Hu S.X. Tetramethylpyrazine protected photoreceptor cells of rats by modulating nuclear translocation of NF-kappaB. Acta Pharmacol. Sin. 26 (2005) 887-892
42. Zhang C., Wang S.Z., Zuo P.P., Cui X., and Cai J. Protective effect of tetramethylpyrazine on learning and memory function in d-galactose-lesioned mice. Chin. Med. Sci. J. 19 (2004) 180-184
43. Zhang Z., Wei T., Hou J., Li G., Yu S., and Xin W. Iron-induced oxidative damage and apoptosis in cerebellar granule cells: attenuation by tetramethylpyrazine and ferulic acid. Eur. J. Pharmacol. 467 (2003) 41-47